×
0 0 -0.0487804878048781 -0.0975609756097562 -0.024390243902439 -0.024390243902439 -0.024390243902439 -0.0853658536585365
Stockreport

BRIEF-Galena Biopharma announces completion of enrollment in two NeuVax™ clinical trials in combination with Trastuzumab [Reuters]

GALENA BIOPHARMA (GALE)  More Company Research Source: Reuters
PDF BRIEF-Galena Biopharma announces completion of enrollment in two NeuVax™ clinical trials in combination with Trastuzumab | Reuters Reuters Staff 1 Min Read Sept 28 (Reuters) - Galena Biopharma Inc * Galena Biopharma Inc announces completion of enrollment in two NeuVax™ (nelipepimut-s) clinical trials in combination with Trastuzumab * Galena Biopharma Inc - ?look forward to interim results next year for phase 2b trial and primary endpoints for both trials in 2019 * Galena Biopharma Inc - ?recommendation from dsmb was to continue her2 3+ trial unmodified? Source text for Eikon: Further company coverage: All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays. © 2017 Reuters. All Rights Reserved. BRIEF-Galena Biopharma announces completion of enrollment in two NeuVax™ clinical trials in combination with Trastuzumab Sept 28 (Reuters) - Galena Biopharma Inc * Galena Biopharma Inc announces completion of enrollment in two NeuVax™ (nelipepimu [Read more]

IMPACT SNAPSHOT EVENT TIME: GALE
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
GALE alerts
from News Quantified
Opt-in for
GALE alerts

from News Quantified
Opt-in for
GALE alerts

from News Quantified